April 20, 2020 /3BL Media/ - UPS (NYSE: UPS) today detailed a comprehensive set of actions it has taken to fight COVID-19 and to keep the American and global economy moving. The company, supported by 495,000 UPSers, its smart logistics network, its technology expertise, and working hand in hand with customers and government, is proactively implementing solutions to ensure life-saving materials and equipment are delivered rapidly to where they are needed most.
LLS Sets Goal of Raising $10 Million from Partners and Donors for New LLS COVID-19 Patient Financial Aid Program Launching April 1
Article
In the wake of the COVID-19 pandemic, The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer, along with valued partners, announced their commitment to help as many blood cancer patients as possible during this unprecedented crisis. The LLS COVID-19 Patient Financial Aid Program will begin immediately to provide $250 to eligible patients struggling with the economic hardship presented by the pandemic.
The path from Amgen Scholars to working at a major pharmaceutical company has been anything but linear for Jan Botthof. Between his undergraduate work, PhD program, and now as a trainee in the International Future Leadership Program for Product Supply at Bayer, Botthof has taken time to try different roles and figure out the best balance of science in his career. Through his journey, Botthof has learned that many career options are available to those with science skills that go beyond traditional benchwork.
November 25, 2019 /3BL Media/ - Amgen was recently named among America’s top corporate citizens on the JUST 100 index for 2020. The latest JUST 100 rankings were published on Nov. 10, 2019, by Forbes and JUST Capital, a non-profit that ranks companies on issues that Americans care about.
Written by Scott Heimlich, Vice President, Amgen Foundation
Blog
Can you imagine the implications to the country and society if we were better able to harness and unleash the talent all around us? What if opportunity and culture unlocked the ambition and dreams of more people – young and old – to achieve their potential? We’re barely scratching the surface.
The path from Amgen Scholars to working at a major pharmaceutical company has been anything but linear for Jan Botthof. Between his undergraduate work, PhD program, and now as a trainee in the International Future Leadership Program for Product Supply at Bayer, Botthof has taken time to try different roles and figure out the best balance of science in his career. Through his journey, Botthof has learned that many career options are available to those with science skills that go beyond traditional benchwork.
Kudos to Amgen Scholars alumni Corshai Williams and Enrique Garcia-Rivera for so eloquently sharing their stories at The Atlantic Education Summit (per this 10-minute session). To learn more of Corshai’s remarkable story, see this profile in the Baltimore Sun.
June 12, 2019 — Amgen is committed to serving patients with innovative medicines to treat serious diseases. In pursuit of this core mission, we have grown over time from a company with a handful of medicines treating hundreds of thousands of patients largely in the U.S. to a company with 20 medicines treating millions of patients in approximately 100 countries around the world.
